Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 3, 2001, Pages 695-704

  Eisbruch, Avraham ^a   Kim, Hyungjin M ^a   Terrell, Jeffrey E ^a,b   Marsh, Lon H ^a   Dawson, Laura A ^a   Ship, Jonathan A ^c  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Head and neck cancer; Intensity modulated radiation therapy; Quality of life; Radiation; Salivary glands; Xerostomia

Indexed keywords

XEROSTOMIA;

BIOLOGICAL ORGANS; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

ONCOLOGY;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; MOUTH CAVITY; PAROTID GLAND; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK FACTOR; SALIVATION; SUBMANDIBULAR GLAND; TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; RADIATION PROTECTION; RADIOTHERAPY, CONFORMAL; RISK FACTORS; SALIVATION; SUBMANDIBULAR GLAND; XEROSTOMIA;

EID: 0035400492     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01512-7     Document Type: Article

References (43)

1. Quality of life in patients treated for head and neck cancer; A follow up study 7 to 11 years after radiotherapy
2. Detailed quality of life assessment in patients treated with irradiation for cancer of the base of tongue
3. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. The University of California-San Francisco experience
4. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy in cancer of the oropharynx and larynx, including the elective neck
5. The potential for sparing of parotids and escalation of biologically effective dose with intensity modulated radiation treatments of head and neck cancer; A treatment design study
6. Intensity-modulated radiation therapy in head and neck cancer; The Mallincrodt experience
7. Modulated beam conformal therapy for head and neck tumors
8. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control
9. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields; Assessment of target coverage and noninvolved tissue sparing
10. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer
11. Rationale and development of a quality of life instrument for head and neck cancer patients
12. Quality of life studies; Definitions and conceptual issues
13. Psychometric validation of the EORTC core quality of life questionnaire and a diagnosis-specific module for head and neck cancer patients
14. Assessment of quality of life in head and neck cancer patients
15. The head and neck radiotherapy questionnaire; A morbidity/quality of life instrument for clinical trials of radiation therapy in head and neck cancer
16. Measuring quality of life; 1995 update
17. Head and neck cancer-specific quality of life; Instrument validation
18. Development of a head and neck companion module for the quality of life-radiation therapy instrument
19. Parotid gland sparing in patients undergoing bilateral head and neck irradiation; Techniques and early results
20. Preservation of parotid function after external beam irradiation in head and neck cancer patients; A feasibility study using 3-dimensional treatment planning
21. Dysphagia in post-irradiation therapy head and neck cancer patients with salivary gland dysfunction; A pilot study
22. Xerostomia. ; Part I: Relationship to other oral symptoms and salivary gland dysfunction
23. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients
24. Subjective reports of xerostomia and objective measures of salivary gland performance
25. Evaluation of stimulated parotid saliva flow rate in different age groups
26. Evaluation of submandibular salivary flow rate in different age groups
27. Random-effects models for longitudinal data
28. A reference guide to drugs and dry mouth
29. Compensatory hyperplasia of the rat submandibular gland following unilateral surgical extirpation
30. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumors
31. Parotid gland function during and following radiotherapy of malignancies in the head and neck
32. How much saliva is enough? 'Normal' function defined
33. Effects of furosemide on the oral cavity
34. The relative contributions of different salivary glands to the blood group activity of whole saliva in humans
35. In defense of the oral cavity; Structure, biosynthesis, and function of salivary mucins
36. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer
37. Parotid sparing without sacrificing target dose uniformity using optimized beamlet IMRT
38. Phase III randomized trial of amifostine as a radioprotector in head, and neck cancer
39. Submandibular salivary gland transfer prevents radiation-induced xerostomia
40. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment; Radiation dose dependency and compensatory mechanisms